<DOC>
	<DOCNO>NCT00787878</DOCNO>
	<brief_summary>The study conduct Europe . The primary aim observational study compare insulin sensitivity small gestational age ( SGA ) subject treated Norditropin速 untreated small gestational age ( SGA ) subject average gestational age ( AGA ) subject .</brief_summary>
	<brief_title>Long Term Metabolic Safety Norditropin速 Treatment Small Gestational Age ( SGA ) Subjects</brief_title>
	<detailed_description />
	<criteria>Norditropin速 treat small gestational age ( SGA ) group : Treated Norditropin速 least three year IUGR1 IUGR2 trial Untreated small gestational age ( SGA ) group : Birth length and/or weight le 2 SDS gestational age Average gestational age ( AGA ) group : Birth length and/or weight large 2 SDS gestational age Growth hormone deficiency define peak growth hormone ( GH ) less 20 mU/l Insulin like growth ( IGF ) 1 level less 2 SDS Receipt investigational drug within four week prior trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>